These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
242 related articles for article (PubMed ID: 26000313)
1. The alteration and clinical significance of Th22/Th17/Th1 cells in patients with chronic myeloid leukemia. Chen P; Wang M; Li D; Jia Y; He N; Li W; Ma D; Ji C J Immunol Res; 2015; 2015():416123. PubMed ID: 26000313 [TBL] [Abstract][Full Text] [Related]
2. Elevated Th22 as well as Th17 cells associated with therapeutic outcome and clinical stage are potential targets in patients with multiple myeloma. Wang M; Chen P; Jia Y; He N; Li D; Ji C; Ma D Oncotarget; 2015 Jul; 6(20):17958-67. PubMed ID: 26255628 [TBL] [Abstract][Full Text] [Related]
3. The existence of Th22, pure Th17 and Th1 cells in CIN and Cervical Cancer along with their frequency variation in different stages of cervical cancer. Zhang W; Tian X; Mumtahana F; Jiao J; Zhang T; Croce KD; Ma D; Kong B; Cui B BMC Cancer; 2015 Oct; 15():717. PubMed ID: 26474968 [TBL] [Abstract][Full Text] [Related]
4. Elevated Th22 cells correlated with Th17 cells in peripheral blood of patients with acute myeloid leukemia. Yu S; Liu C; Zhang L; Shan B; Tian T; Hu Y; Shao L; Sun Y; Ji C; Ma D Int J Mol Sci; 2014 Jan; 15(2):1927-45. PubMed ID: 24473142 [TBL] [Abstract][Full Text] [Related]
5. Increased Th22 cells as well as Th17 cells in patients with adult T-cell acute lymphoblastic leukemia. Tian T; Sun Y; Li M; He N; Yuan C; Yu S; Wang M; Ji C; Ma D Clin Chim Acta; 2013 Nov; 426():108-13. PubMed ID: 24064425 [TBL] [Abstract][Full Text] [Related]
6. Increased AHR Transcripts Correlate With Pro-inflammatory T-Helper Lymphocytes Polarization in Both Metabolically Healthy Obesity and Type 2 Diabetic Patients. Zhao RX; He Q; Sha S; Song J; Qin J; Liu P; Sun YJ; Sun L; Hou XG; Chen L Front Immunol; 2020; 11():1644. PubMed ID: 32849564 [TBL] [Abstract][Full Text] [Related]
7. Elevated profiles of Th22 cells and correlations with Th17 cells in patients with immune thrombocytopenia. Hu Y; Li H; Zhang L; Shan B; Xu X; Li H; Liu X; Xu S; Yu S; Ma D; Peng J; Hou M Hum Immunol; 2012 Jun; 73(6):629-35. PubMed ID: 22537755 [TBL] [Abstract][Full Text] [Related]
8. The Profile of T Helper Subsets in Bone Marrow Microenvironment Is Distinct for Different Stages of Acute Myeloid Leukemia Patients and Chemotherapy Partly Ameliorates These Variations. Tian T; Yu S; Liu L; Xue F; Yuan C; Wang M; Ji C; Ma D PLoS One; 2015; 10(7):e0131761. PubMed ID: 26134277 [TBL] [Abstract][Full Text] [Related]
9. Circulating Th22 cells, as well as Th17 cells, are elevated in patients with renal cell carcinoma. Peng Z; Hu Y; Ren J; Yu N; Li Z; Xu Z Int J Med Sci; 2021; 18(1):99-108. PubMed ID: 33390778 [TBL] [Abstract][Full Text] [Related]
10. Medroxyprogesterone Acetate Decreases Th1, Th17, and Increases Th22 Responses via AHR Signaling Which Could Affect Susceptibility to Infections and Inflammatory Disease. Piccinni MP; Lombardelli L; Logiodice F; Kullolli O; Maggi E; Barkley MS Front Immunol; 2019; 10():642. PubMed ID: 31001262 [TBL] [Abstract][Full Text] [Related]
11. Existence of Th22 in children and evaluation of IL-22 + CD4 + T, Th17, and other T cell effector subsets from healthy children compared to adults. Shen E; Wang M; Xie H; Zou R; Lin Q; Lai L; Li F; Liang Z; Xu Y; Zhou M BMC Immunol; 2016 Jun; 17(1):20. PubMed ID: 27338754 [TBL] [Abstract][Full Text] [Related]
12. Down-regulation of the Th1, Th17, and Th22 pathways due to anti-TNF-α treatment in psoriasis. Luan L; Han S; Wang H; Liu X Int Immunopharmacol; 2015 Dec; 29(2):278-284. PubMed ID: 26585971 [TBL] [Abstract][Full Text] [Related]
13. Increased circulating T‑helper 22 cells in patients with dilated cardiomyopathy. Kong Q; Li X; Wu W; Yang F; Liu Y; Lai W; Pan X; Gao M; Xue Y Mol Med Rep; 2014 Jul; 10(1):359-64. PubMed ID: 24737285 [TBL] [Abstract][Full Text] [Related]
14. Increased interleukin-27 promotes Th1 differentiation in patients with chronic immune thrombocytopenia. Li Q; Zhang L; Yang M; Xia R; Xia L; Liu F Scand J Immunol; 2014 Oct; 80(4):276-82. PubMed ID: 24909905 [TBL] [Abstract][Full Text] [Related]
15. Analysis of Th22, Th17 and CD4 Doulabi H; Rastin M; Shabahangh H; Maddah G; Abdollahi A; Nosratabadi R; Esmaeili SA; Mahmoudi M Biomed Pharmacother; 2018 Jul; 103():1101-1106. PubMed ID: 29710675 [TBL] [Abstract][Full Text] [Related]
16. Circulating Th17, Th22, and Th1 cells are elevated in the Guillain-Barré syndrome and downregulated by IVIg treatments. Li S; Jin T; Zhang HL; Yu H; Meng F; Concha Quezada H; Zhu J Mediators Inflamm; 2014; 2014():740947. PubMed ID: 24899787 [TBL] [Abstract][Full Text] [Related]
17. Th22 cells as well as Th17 cells expand differentially in patients with early-stage and late-stage myelodysplastic syndrome. Shao LL; Zhang L; Hou Y; Yu S; Liu XG; Huang XY; Sun YX; Tian T; He N; Ma DX; Peng J; Hou M PLoS One; 2012; 7(12):e51339. PubMed ID: 23236476 [TBL] [Abstract][Full Text] [Related]
18. A high frequency of circulating th22 and th17 cells in patients with new onset graves' disease. Peng D; Xu B; Wang Y; Guo H; Jiang Y PLoS One; 2013; 8(7):e68446. PubMed ID: 23874630 [TBL] [Abstract][Full Text] [Related]
19. Decreased percentages of regulatory T cells are necessary to activate Th1-Th17-Th22 responses during acute rejection of the peripheral nerve xenotransplantation in mice. Chai H; Yang L; Gao L; Guo Y; Li H; Fan X; Wu B; Xue S; Cai Y; Jiang X; Qin B; Zhang S; Ke Y Transplantation; 2014 Oct; 98(7):729-37. PubMed ID: 25093516 [TBL] [Abstract][Full Text] [Related]
20. Th22, but not Th17 might be a good index to predict the tissue involvement of systemic lupus erythematosus. Yang XY; Wang HY; Zhao XY; Wang LJ; Lv QH; Wang QQ J Clin Immunol; 2013 May; 33(4):767-74. PubMed ID: 23435610 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]